PSYCHOLOGICAL FEATURES OF PERSONS WITH MYOPIA AND THEIR INFLUENCE ON COMPLIANCE

Connecon of the publicaon with planned research works.This work was carried out in accordance with the plan of the research work of the Department of Ophthalmology of the Bogomolets Naonal Medical University of the Ministry of Health of Ukraine "Improvement of diagnoscs and treatment of renal and opc nerve pathology of vascular, traumac and endocrine genesis" (state registraon number 0120U100810).Introducon.Myopia is one of the leading health care problems in the world [1].According to the European Society of Ophthalmology, the prevalence of myopia is predicted to reach 50-56% in Eastern and Western Europe and 65% in Asia by 2050.Over the past decades, the prevalence of myopia in Europe has reached 45-50% in people aged 25-29 [1].Myopia is a health care problem due to its impact on the quality of life [2] and social funconing [3] of young people, and the risk of myopic maculopathy and opc neuropathy in eyes with high myopia [4], cataracts, glaucoma and renal detachment [5], which can lead to signicant visual impairment.Currently, there is no safe threshold level of myopia, and even mild to moderate myopia can lead to life-threatening complicaons [6].The problem of adherence to treatment is mulfactorial, as it is inuenced by many factors [7], but to date there are no randomized trials on this issue [8].Several studies have shown that good adherence to treatment leads to improved clinical outcomes [9,10].Longer dura-on of so contact lens wear is associated with greater ecacy in controlling myopia [9], and good compliance is associated with improved visual acuity with orthokeratology treatment [10].Despite the proven eecveness of atropine [11], so contact lenses for myopia control [12], and orthokeratology [13,14], the problem of adherence to treatment is sll far from being fully understood.A study by Jun J. et al., 2018, showed that full compliance with orthokeratology treatment, including wearing, care, and follow-up visits, was only 14.1% [13].Longer treatment duraon, lower ascending myopia, lower high-contrast visual acuity, side eects, and ocular discomfort are as-